Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-16-014285
Filing Date
2016-06-16
Accepted
2016-06-16 15:32:21
Documents
2
Period of Report
2016-06-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO CURRENT REPORT f8k061616a1_immucellcorp.htm 8-K/A 42368
2 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF IMMUCELL CORPORATION f8k061616a1ex3i_immucellcorp.htm EX-3.1 10300
  Complete submission text file 0001213900-16-014285.txt   53860
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-12934 | Film No.: 161717533
SIC: 2835 In Vitro & In Vivo Diagnostic Substances